MedTrace Logo

Quality Initiative in Rectal Cancer (QIRC) Trial

NCT00182130 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 691

Last updated 2005-09-16

No results posted yet for this study

Summary

The Quality initiative in rectal cancer (QIRC) trial will test if a strategy designed to positively influence surgeon practice can decrease hospital rates of permanent colostomy and local tumour recurrence for surgically treated rectal cancer patients.

Conditions

Interventions

PROCEDURE

Quality Initiative in Rectal Cancer (QIRC) strategy

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Marko Simunovic, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Completion
2007-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182130 on ClinicalTrials.gov